Breaking News Instant updates and real-time market news.

IBM

IBM

$158.49

4.24 (2.75%)

, EXPE

Expedia

$125.17

3.75 (3.09%)

08:24
01/04/18
01/04
08:24
01/04/18
08:24

IBM sues Expedia alleging patent infringement, GeekWire reports

IBM (IBM) is suing Expedia (EXPE) and seeking compensation alleging the travel company's website, mobile apps and subsidiaries have infringed upon several of its patents regarding content delivery, GeekWire reports, citing the lawsuit. "Defendants have built their business model on the use of IBM's patents. Moreover, despite IBM's repeated attempts to negotiate, defendants refuse to negotiate a license," the lawsuit said. "Because IBM's over six-year struggle to negotiate a license agreement that remedies defendants' unlawful conduct has failed, IBM has been forced to seek relief through litigation."Reference Link

IBM

IBM

$158.49

4.24 (2.75%)

EXPE

Expedia

$125.17

3.75 (3.09%)

  • 08

    Jan

IBM IBM
$158.49

4.24 (2.75%)

11/16/17
PIPR
11/16/17
NO CHANGE
Target $60
PIPR
Overweight
NetApp price target raised to $60 from $52 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for NetApp to $60 saying the company reported "very strong" Q2 results, with all metrics exceeding the mid-point of guidance and consensus. The quarter shows that NetApp continues to take share from HP (HPQ), Dell/EMC and IBM (IBM), Nowinski tells investors in a post-earnings research note. He expects the share gains to continue and reiterates an Overweight rating on NetApp shares.
01/03/18
RBCM
01/03/18
UPGRADE
RBCM
Outperform
IBM upgraded to Outperform from Sector Perform at RBC Capital
01/03/18
RBCM
01/03/18
UPGRADE
Target $180
RBCM
Outperform
IBM upgraded to Outperform at RBC Capital on mainframe cycle and valuation
As reported earlier, RBC Capital analyst Amit Daryanani upgraded IBM to Outperform from Sector Perform and raised his price target to $180 from $160. Daryanani points to the benefits of the mainframe cycle upgrade, a favorable FX backdrop for the first time in 3 years, recovery in hybrid IT spending leading to 1%-3% revenue growth, and attractive 11-times PE valuation. The analyst adds that gross margins could stabilize in 2018 after an expected 130bps decline in 2017.
01/03/18
01/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Mills (GIS) upgraded to Neutral from Underweight at Piper Jaffray with analyst Michael Lavery saying he expects the company to use some of its tax reform benefit to increase "needed" brand investments. He sees the company posting 9%-10% average earnings growth over the next six quarters. 2. Ulta Beauty (ULTA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying he sees "compelling setup" for the shares in 2018 given the company's "material" tax benefit and potential for fundamental stabilization. 3. IBM (IBM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Amit Daryanani citing the benefits of the mainframe cycle upgrade, a favorable FX backdrop for the first time in 3 years, recovery in hybrid IT spending leading to 1%-3% revenue growth, and attractive 11-times PE valuation. 4. Oracle (ORCL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Keith Weiss arguing that its current low valuation with cloud expectations diminished following its last three earnings reports presents "a tactical opportunity for old fashioned earnings growth to drive the shares higher." 5. United Technologies (UTX) upgraded to Outperform from Sector Perform at RBC Capital analyst Deane Dray saying 2018 will mark the final year of margin pressure at the company's Pratt and Otis units which led to the recent underperformance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EXPE Expedia
$125.17

3.75 (3.09%)

12/07/17
12/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Underweight from Neutral at Piper Jaffray with analyst Sam Kemp saying given the "messiness" of removing Eat24, investors missed that Yelp lowered organic fourth quarter guidance by 2%. 2. Toll Brothers (TOL) downgraded to Outperform from Strong Buy at Raymond James with analyst Buck Horne saying fiscal 2018 gross margins are more cautious than expected due to New York City headwinds ahead of an upcoming supply wave. 3. Priceline (PCLN) and Expedia (EXPE) were downgraded to Neutral from Buy at MKM Partners. 4. Ctrip.com (CTRP) downgraded to Neutral from Overweight at JPMorgan with analyst Alex Yao saying the introduced an opt-in option in early October by removing part of the default purchase setting of bundled products. 5. Allergan (AGN) downgraded to Hold from Buy at Argus analyst David Toung saying the company's Botox may face increasing competition from a botulinum toxin-based product being developed by Revance Therapeutics (RVNC) by 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/17
DBAB
12/19/17
NO CHANGE
Target $150
DBAB
Buy
HomeAway hikes prices on new subscription listings, says Deutsche Bank
Expedia's HomeAway recently sent an email indicating it is increasing the annual subscription listing fee starting on January 12, 2018 from $399 to $499 per listing per year, Deutsche Bank analyst Lloyd Walmsley tells investors in a research note. The analyst believes the subscription price hikes alone could be worth $41M of high incremental margin revenue in 2018 and $37M in 2019. Further, the price hikes should help improve monetization, underscoring the vacation rental opportunity at Expedia, Walmsley contends. He views Expedia's recent 2018 guidance removal at HomeAway as conservative and keeps a Buy rating on the shares with a $150 price target.
01/03/18
BOFA
01/03/18
UPGRADE
BOFA
Buy
Expedia upgraded to Buy from Neutral at BofA/Merrill
01/03/18
BOFA
01/03/18
UPGRADE
Target $145
BOFA
Buy
Expedia upgraded to Buy following a reset in expectations at BofA/Merrill
As previously reported, BofA/Merrill upgraded Expedia to Buy from Neutral with a $145 price target. Analyst Justin Post sees an attractive risk/reward setup for Expedia shares given reasonable 2018 EBITDA expectations, potential benefit from a pullback in Priceline ad spending, HomeAway's growth opportunity, online travel agency industry penetration, and attractive core 2019 OTA EBTIDA valuation.

TODAY'S FREE FLY STORIES

CREE

Cree

$50.17

-0.11 (-0.22%)

, ZTCOY

ZTE Corp.

$0.00

(0.00%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Recommendations
Cree, ZTE Corp. analyst commentary  »

Cree organic growth above…

CREE

Cree

$50.17

-0.11 (-0.22%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DRYS

DryShips

$4.60

-0.05 (-1.08%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Hot Stocks
DryShips announces sale of Panamax drybulk carrier »

DryShips announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Conference/Events
The Washington Journal holds a discussion on NAFTA renegotiations & trade policy »

Public Citizen Global…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. retail sales rose 0.5% in July, with the ex-auto component up 0.6% »

U.S. retail sales rose…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

, ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

08:45
08/15/18
08/15
08:45
08/15/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

JNK

SPDR Barclays High Yield Bond

$35.86

0.065 (0.18%)

IRBT

iRobot

$87.83

1.72 (2.00%)

ENB

Enbridge

$35.51

0.3108 (0.88%)

WLL

Whiting Petroleum

$48.18

1.73 (3.72%)

HEAR

Turtle Beach

$26.80

-1.15 (-4.11%)

AMJ

American Medical Laboratories Inc

$29.11

0.2 (0.69%)

UCO

Universal Compression

$29.37

-0.06 (-0.20%)

GOGO

Gogo

$4.42

0.05 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 13

    Sep

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. Empire State manufacturing index bounced 3 points to 25.6 in August »

U.S. Empire State…

08:42
08/15/18
08/15
08:42
08/15/18
08:42
Conference/Events
RBC Capital to hold a conference »

Consumer Investor Day…

08:41
08/15/18
08/15
08:41
08/15/18
08:41
Conference/Events
Stephens to hold a field trip »

Building Products…

BKH

Black Hills

$60.23

0.235 (0.39%)

, GGG

Graco

$46.02

0.025 (0.05%)

08:40
08/15/18
08/15
08:40
08/15/18
08:40
Conference/Events
CFA Society of Minnesota to hold a conference »

7th Annual Investor…

BKH

Black Hills

$60.23

0.235 (0.39%)

GGG

Graco

$46.02

0.025 (0.05%)

CLFD

Clearfield

$13.05

0.35 (2.76%)

CYBE

Cyberoptics

$19.25

0.05 (0.26%)

CHRW

C.H. Robinson

$93.98

0.02 (0.02%)

DAKT

Daktronics

$8.43

0.02 (0.24%)

CBZ

CBIZ

$22.93

0.275 (1.21%)

DGII

Digi International

$12.95

-0.025 (-0.19%)

PII

Polaris Industries

$107.72

0.42 (0.39%)

ASV

ASV Holdings

$6.28

-0.27 (-4.12%)

ALE

Allete

$77.99

0.97 (1.26%)

DOC

Physicians Realty Trust

$16.83

0.22 (1.32%)

APOG

Apogee Enterprises

$49.74

0.55 (1.12%)

MOS

Mosaic

$30.63

0.25 (0.82%)

DCI

Donaldson

$47.69

0.88 (1.88%)

SRDX

Surmodics

$73.05

2.1 (2.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 26

    Aug

  • 06

    Sep

  • 06

    Sep

  • 29

    Oct

  • 06

    Nov

SHLX

Shell Midstream

$22.73

0.35 (1.56%)

08:39
08/15/18
08/15
08:39
08/15/18
08:39
Hot Stocks
Shell Midstream joint venture Zydeco announces binding open season »

Zydeco, jointly owned by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:37
08/15/18
08/15
08:37
08/15/18
08:37
Hot Stocks
Breaking Hot Stocks news story on KMG Chemicals »

KMG Chemicals trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$129.47

-0.67 (-0.51%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

IDXG

Interpace Diagnostics

$1.03

-0.01 (-0.96%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Hot Stocks
Interpace Diagnostics acquires assets of Rosetta Genomics out of bankruptcy »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$193.08

-1.03 (-0.53%)

08:34
08/15/18
08/15
08:34
08/15/18
08:34
Recommendations
Home Depot analyst commentary  »

Stifel sees 'no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$1.03

(0.00%)

08:33
08/15/18
08/15
08:33
08/15/18
08:33
Hot Stocks
CEL-SCI says IDMC recommends continuation of Phase 3 head and neck cancer study »

CEL-SCI announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:33
08/15/18
08/15
08:33
08/15/18
08:33
General news
Empire State Mfg Survey General Business Conditions Index data reported »

August Empire State Mfg…

CE

Celanese

$116.73

0.7 (0.60%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Hot Stocks
Celanese granted four new patents for Sunett sweetner »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CYTX

Cytori Therapeutics

$0.40

0.015 (3.95%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Downgrade
Cytori Therapeutics rating change  »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

, CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Conference/Events
Cabot Microelectronics to hold a conference call »

Conference call to…

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

TPR

Tapestry

$53.12

5.7 (12.02%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Recommendations
Tapestry analyst commentary  »

Tapestry price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

, KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Hot Stocks
Cabot Microelectronics to acquire KMG Chemicals for $1.6B »

Cabot Microelectronics…

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

, JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Options
One new option listing and three option delistings on August 15th »

New option listings for…

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

XPLR

Xplore Technologies

$5.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$32.28

-1.72 (-5.06%)

08:28
08/15/18
08/15
08:28
08/15/18
08:28
Recommendations
Neuronetics analyst commentary  »

Neuronetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNC

Tennant

$76.60

-0.85 (-1.10%)

08:28
08/15/18
08/15
08:28
08/15/18
08:28
Conference/Events
Tennant management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.